Amlodipine group (mean±SD) | Control group (mean±SD) | Mean difference (95% CI) | p Value | |
---|---|---|---|---|
Platelet reactivity unit (primary end-point) | 227±84 | 214±90 | 12.7 (−22 to +47) | 0.47 |
Platelet inhibition, % (secondary end-point) | 33±22 | 38±25 | −4.5 (−14 to +5.0) | 0.34 |
No. of poor responder to clopidogrel, n (%) (secondary end-point) | 24 (49%) | 22 (45%) | – | 0.76 |